Sagartz John E 4
4 · BIOANALYTICAL SYSTEMS INC · Filed Mar 14, 2019
Insider Transaction Report
Form 4
Sagartz John E
Chief Strategy Officer
Transactions
- Purchase
Common Shares
2019-03-14$1.94/sh+1,400$2,716→ 3,900 total
Holdings
- 617,625(indirect: See Footnote)
Common Shares
Footnotes (1)
- [F1]The Reporting Person owns 41.175% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, which owns 1,500,000 common shares of the Issuer. The Reporting Person is Co-President and Chief Strategy Officer of SW Chrysalis, LLC.